ARCHIVES

Report: Rising Treatment Costs Due to 340B Discounts

This article is from The Cancer Letter archive.

Vol. 40 No. 20 | May 16, 2014

Download PDF Visit The Full Archive

Related Articles

Alan Rabson Named Acting NCI Director

October 5, 2001

Phase III PANORAMA-1 Trial Meets PFS Primary Endpoint

June 27, 2014

In Brief: Phil Amoruso Will Be The New NCI Executive Officer; DRCCA Board Okays CCN Extension

January 2, 1981

House Still Sees Problems In NIH Financial Management

July 5, 1991

Frank Torti Named FDA Deputy Commissioner, To Take Leave As Wake Forest Center Director.

April 11, 2008

Senate Voices Discontent With NIH, NCI Budget; Gorton Presses Raub On Cancer’s ‘Low Priority’

March 22, 1991